FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2611246002> ?p ?o ?g. }

• W2611246002 abstract "Abstract Abstract 1270 Poster Board I-292 3-Indole-acetic acid (IAA) is a growth hormone found in plants that may be oxidized by horseradish peroxidase (HRP) generating cytotoxic molecules capable of inducing injury in mammal cells, including a variety of human tumors. The aim of this study was to establish an assay based on targeting HRP to hematopoietic tumor cells using antibodies and induce apoptosis by incubation with IAA. To set up the best experimental conditions, we used two human lineages of hematologic tumors: NB4, derived from acute promyelocytic leukemia (APL) and Granta 519, from Mantle Cell Lymphoma (MCL). The targeting of HRP was performed with anti-CD33 or anti-CD19 antibodies (depending on the origin of the cell), followed by incubation with goat anti-mouse antibody conjugated with the enzyme. Eight groups of cells were incubated for 2, 8, 18, 24 and 48 hours: control, HRP targeted, HRP targeted with IAA at 1, 5 and 10 mM, cells not targeted with IAA at 1, 5 and 10 mM. Apoptosis was analyzed by flow cytometry, with anexin V-FITC and propidium iodide. The best experimental conditions for both NB4 and Granta 519 cells were achieved with incubation for 24 h with 10 mM IAA. For NB4, the group targeted with HRP and treated with 10 mM IAA for 24 hours presented 44.1% of apoptosis, whereas the control groups achieved 18.2 to 24.6% (P<0.05). In Granta 519, these results demonstrated higher values of cell death (64.1% versus 15.5 to 20.6% in control groups, P<0.05). Next, we tested cells from 12 patients with acute myeloid leukemia (AML) (six with APL and six with AML others than APL) and from 10 patients with chronic lymphocytic leukemia (CLL). In AML patients others than APL, cells targeted with HRP and treated for 24 h with 10 mM IAA presented 78.8% of apoptosis, while the results with control groups varied from 18.5 to 27.8% (P<0.05). These group of cells in APL patients presented 75.9% of apoptosis, while the controls varied from 18.1 to 44.8% (P<0.05). Interestingly, in APL patients, the cell group treated with 10 mM IAA and not targeted with HRP also had higher apoptosis (44.8%) when compared to the others controls (18.1 to 26.8%) (P<0.05), suggesting that the high concentrations of myeloperoxidase of these cells were capable of activating IAA, in the absence of HRP. In CLL, cells incubated for 24 hours, targeted with HRP and treated 10 mM IAA showed mean apoptosis value of 93.3%. In the control cells, these values varied from 35.7 to 53.7% (P<0.05). Interestingly, cells from patients with CLL presented higher apoptosis than AML cells (P<0.05). Our results demonstrated that the IAA/HRP association was capable of inducing apoptosis in hematopoietic tumors, which was dependant on the IAA dose, the time of IAA exposure and the lineage of the tumor. It is also suggested that the endogenous myeloperoxidase found in APL blasts was capable of activating HRP in the absence of IAA, leading to death of these cells. Disclosures No relevant conflicts of interest to declare." @default.
• W2611246002 created "2017-05-12" @default.
• W2611246002 creator A5030420578 @default.
• W2611246002 creator A5036414211 @default.
• W2611246002 creator A5066436306 @default.
• W2611246002 creator A5074453675 @default.
• W2611246002 creator A5085760081 @default.
• W2611246002 creator A5090660802 @default.
• W2611246002 creator A5091101314 @default.
• W2611246002 date "2009-11-20" @default.
• W2611246002 modified "2023-10-14" @default.
• W2611246002 title "Antibody-Targeted HRP Associated with Indole-3-Acetic Acid Induces in Vitro Apoptosis in Hematological Tumors." @default.
• W2611246002 doi "https://doi.org/10.1182/blood.v114.22.1270.1270" @default.
• W2611246002 hasPublicationYear "2009" @default.
• W2611246002 type Work @default.
• W2611246002 sameAs 2611246002 @default.
• W2611246002 citedByCount "0" @default.
• W2611246002 crossrefType "journal-article" @default.
• W2611246002 hasAuthorship W2611246002A5030420578 @default.
• W2611246002 hasAuthorship W2611246002A5036414211 @default.
• W2611246002 hasAuthorship W2611246002A5066436306 @default.
• W2611246002 hasAuthorship W2611246002A5074453675 @default.
• W2611246002 hasAuthorship W2611246002A5085760081 @default.
• W2611246002 hasAuthorship W2611246002A5090660802 @default.
• W2611246002 hasAuthorship W2611246002A5091101314 @default.
• W2611246002 hasConcept C153911025 @default.
• W2611246002 hasConcept C154317977 @default.
• W2611246002 hasConcept C159654299 @default.
• W2611246002 hasConcept C181199279 @default.
• W2611246002 hasConcept C185592680 @default.
• W2611246002 hasConcept C190283241 @default.
• W2611246002 hasConcept C202751555 @default.
• W2611246002 hasConcept C203014093 @default.
• W2611246002 hasConcept C2775934118 @default.
• W2611246002 hasConcept C2777676563 @default.
• W2611246002 hasConcept C31573885 @default.
• W2611246002 hasConcept C502942594 @default.
• W2611246002 hasConcept C553184892 @default.
• W2611246002 hasConcept C55493867 @default.
• W2611246002 hasConcept C86803240 @default.
• W2611246002 hasConceptScore W2611246002C153911025 @default.
• W2611246002 hasConceptScore W2611246002C154317977 @default.
• W2611246002 hasConceptScore W2611246002C159654299 @default.
• W2611246002 hasConceptScore W2611246002C181199279 @default.
• W2611246002 hasConceptScore W2611246002C185592680 @default.
• W2611246002 hasConceptScore W2611246002C190283241 @default.
• W2611246002 hasConceptScore W2611246002C202751555 @default.
• W2611246002 hasConceptScore W2611246002C203014093 @default.
• W2611246002 hasConceptScore W2611246002C2775934118 @default.
• W2611246002 hasConceptScore W2611246002C2777676563 @default.
• W2611246002 hasConceptScore W2611246002C31573885 @default.
• W2611246002 hasConceptScore W2611246002C502942594 @default.
• W2611246002 hasConceptScore W2611246002C553184892 @default.
• W2611246002 hasConceptScore W2611246002C55493867 @default.
• W2611246002 hasConceptScore W2611246002C86803240 @default.
• W2611246002 hasLocation W26112460021 @default.
• W2611246002 hasOpenAccess W2611246002 @default.
• W2611246002 hasPrimaryLocation W26112460021 @default.
• W2611246002 hasRelatedWork W1636604504 @default.
• W2611246002 hasRelatedWork W1960953338 @default.
• W2611246002 hasRelatedWork W2000499173 @default.
• W2611246002 hasRelatedWork W2023829738 @default.
• W2611246002 hasRelatedWork W2024014454 @default.
• W2611246002 hasRelatedWork W2033337173 @default.
• W2611246002 hasRelatedWork W2064832291 @default.
• W2611246002 hasRelatedWork W2082259604 @default.
• W2611246002 hasRelatedWork W2092621632 @default.
• W2611246002 hasRelatedWork W2104292098 @default.
• W2611246002 hasRelatedWork W2286540978 @default.
• W2611246002 hasRelatedWork W2326498985 @default.
• W2611246002 hasRelatedWork W2341602834 @default.
• W2611246002 hasRelatedWork W2342385077 @default.
• W2611246002 hasRelatedWork W2405904116 @default.
• W2611246002 hasRelatedWork W2414035948 @default.
• W2611246002 hasRelatedWork W2416528519 @default.
• W2611246002 hasRelatedWork W2810529339 @default.
• W2611246002 hasRelatedWork W1954884169 @default.
• W2611246002 hasRelatedWork W2826655256 @default.
• W2611246002 isParatext "false" @default.
• W2611246002 isRetracted "false" @default.
• W2611246002 magId "2611246002" @default.
• W2611246002 workType "article" @default.